FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130897847> ?p ?o ?g. }

• W2130897847 endingPage "923" @default.
• W2130897847 startingPage "917" @default.
• W2130897847 abstract "Background. A variety of stimuli are involved in the pathogenesis of parathyroid gland hyperplasia in renal failure. Recently, it was shown that blocking the signal from the endothelin-1 (ET-1) receptor (ETAR/ETBR) by a non-selective receptor antagonist, bosentan, reduced parathyroid cell proliferation, parathyroid gland hyperplasia and parathyroid hormone (PTH) levels in normal rats on a calcium deficient diet. Our goal was to determine whether in 5/6 nephrectomized (NPX) rats with developing or established hyperparathyroidism, the endothelin receptor blocker, bosentan, reduced the increase in parathyroid cell proliferation, parathyroid gland hyperplasia and PTH values. Methods. High (HPD, 1.2%) or normal phosphorus diets (PD) (NPD, 0.6%) were given to 5/6 NPX rats for 15 days (NPX15). In each dietary group, one-half the rats were given bosentan (B) i.p. 100 mg/kg/day. The four groups of rats were: (1) NPX15-1.2% P; (2) NPX15-1.2% P+B; (3) NPX15-0.6% P; and (4) NPX15-0.6% P+B. In a second study in which hyperparathyroidism was already established in 5/6 NPX rats fed a HPD for 15 days, rats were divided into two groups in which one group was maintained on a HPD and the other group was changed to very low PD (VLPD, <0.05%) for an additional 15 days. In each dietary group, one-half the rats were given bosentan i.p. 100 mg/kg-day. The four groups of rats were: (1) NPX30-1.2% P; (2) NPX30-1.2% P+B; (3) NPX30-0.05% P and (4) NPX30-0.05% P+B. Parathyroid cell proliferation was measured by proliferating cell nuclear antigen (PCNA) staining and ET-1 expression by immunohistochemical techniques. Results. In the study of developing hyperparathyroidism, bosentan reduced ET-1 expression in the parathyroid glands of rats on the NPD and HPD (P<0.05). But only in rats on the NPD did bosentan result in a reduced increase in parathyroid gland weight (P<0.05). In the study of established hyperparathyroidism, in which 5/6 NPX rats were given a HPD for 15 days, bosentan started on day 15 reduced (P<0.05) ET-1 expression in rats maintained for 15 additional days on the HPD or the VLPD. On the VLPD, parathyroid gland weight was less (P<0.05) than that in rats on the HPD sacrificed at 15 or 30 days. Bosentan did not reduce parathyroid cell proliferation or parathyroid gland weight in rats maintained on the HPD or further reduce these parameters beyond that obtained with dietary phosphorus restriction. PTH values were lowest in the VLPD group, intermediate in the NPD group, and highest in the HPD group, but in none of the three groups did bosentan decrease PTH values. Conclusions. In azotemic rats with developing hyperparathyroidism, bosentan resulted in a reduced increase in parathyroid gland weight when dietary phosphorus content was normal. Despite a reduction in ET-1 expression in rats on a HPD with developing or established hyperparathyroidism, bosentan did not reduce the increase in parathyroid cell proliferation, parathyroid gland growth or PTH values. Thus, ET-1 blockade with bosentan did not prevent parathyroid gland growth in the azotemic rat." @default.
• W2130897847 created "2016-06-24" @default.
• W2130897847 creator A5012999223 @default.
• W2130897847 creator A5013963480 @default.
• W2130897847 creator A5055791918 @default.
• W2130897847 creator A5064306007 @default.
• W2130897847 creator A5067509002 @default.
• W2130897847 creator A5082490137 @default.
• W2130897847 creator A5087093541 @default.
• W2130897847 date "2006-01-23" @default.
• W2130897847 modified "2023-10-15" @default.
• W2130897847 title "Effect of endothelin receptor antagonist on parathyroid gland growth, PTH values and cell proliferation in azotemic rats" @default.
• W2130897847 cites W1978885132 @default.
• W2130897847 cites W1985265072 @default.
• W2130897847 cites W2004142918 @default.
• W2130897847 cites W2005393700 @default.
• W2130897847 cites W2007206760 @default.
• W2130897847 cites W2050356686 @default.
• W2130897847 cites W2051709807 @default.
• W2130897847 cites W2052969704 @default.
• W2130897847 cites W2068332720 @default.
• W2130897847 cites W2074577319 @default.
• W2130897847 cites W2083168164 @default.
• W2130897847 cites W2086832511 @default.
• W2130897847 cites W2101793653 @default.
• W2130897847 cites W2105511151 @default.
• W2130897847 cites W2162804111 @default.
• W2130897847 cites W2322088784 @default.
• W2130897847 doi "https://doi.org/10.1093/ndt/gfk006" @default.
• W2130897847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16431896" @default.
• W2130897847 hasPublicationYear "2006" @default.
• W2130897847 type Work @default.
• W2130897847 sameAs 2130897847 @default.
• W2130897847 citedByCount "5" @default.
• W2130897847 countsByYear W21308978472012 @default.
• W2130897847 countsByYear W21308978472013 @default.
• W2130897847 crossrefType "journal-article" @default.
• W2130897847 hasAuthorship W2130897847A5012999223 @default.
• W2130897847 hasAuthorship W2130897847A5013963480 @default.
• W2130897847 hasAuthorship W2130897847A5055791918 @default.
• W2130897847 hasAuthorship W2130897847A5064306007 @default.
• W2130897847 hasAuthorship W2130897847A5067509002 @default.
• W2130897847 hasAuthorship W2130897847A5082490137 @default.
• W2130897847 hasAuthorship W2130897847A5087093541 @default.
• W2130897847 hasConcept C126322002 @default.
• W2130897847 hasConcept C134018914 @default.
• W2130897847 hasConcept C144980905 @default.
• W2130897847 hasConcept C149601957 @default.
• W2130897847 hasConcept C170493617 @default.
• W2130897847 hasConcept C2775945674 @default.
• W2130897847 hasConcept C2776345702 @default.
• W2130897847 hasConcept C2776885963 @default.
• W2130897847 hasConcept C2777562237 @default.
• W2130897847 hasConcept C2778122271 @default.
• W2130897847 hasConcept C2778248654 @default.
• W2130897847 hasConcept C2778838027 @default.
• W2130897847 hasConcept C2781109936 @default.
• W2130897847 hasConcept C2781208988 @default.
• W2130897847 hasConcept C519063684 @default.
• W2130897847 hasConcept C71924100 @default.
• W2130897847 hasConceptScore W2130897847C126322002 @default.
• W2130897847 hasConceptScore W2130897847C134018914 @default.
• W2130897847 hasConceptScore W2130897847C144980905 @default.
• W2130897847 hasConceptScore W2130897847C149601957 @default.
• W2130897847 hasConceptScore W2130897847C170493617 @default.
• W2130897847 hasConceptScore W2130897847C2775945674 @default.
• W2130897847 hasConceptScore W2130897847C2776345702 @default.
• W2130897847 hasConceptScore W2130897847C2776885963 @default.
• W2130897847 hasConceptScore W2130897847C2777562237 @default.
• W2130897847 hasConceptScore W2130897847C2778122271 @default.
• W2130897847 hasConceptScore W2130897847C2778248654 @default.
• W2130897847 hasConceptScore W2130897847C2778838027 @default.
• W2130897847 hasConceptScore W2130897847C2781109936 @default.
• W2130897847 hasConceptScore W2130897847C2781208988 @default.
• W2130897847 hasConceptScore W2130897847C519063684 @default.
• W2130897847 hasConceptScore W2130897847C71924100 @default.
• W2130897847 hasIssue "4" @default.
• W2130897847 hasLocation W21308978471 @default.
• W2130897847 hasLocation W21308978472 @default.
• W2130897847 hasOpenAccess W2130897847 @default.
• W2130897847 hasPrimaryLocation W21308978471 @default.
• W2130897847 hasRelatedWork W1968744650 @default.
• W2130897847 hasRelatedWork W1974227996 @default.
• W2130897847 hasRelatedWork W1993773297 @default.
• W2130897847 hasRelatedWork W2028161615 @default.
• W2130897847 hasRelatedWork W2056338187 @default.
• W2130897847 hasRelatedWork W2412586810 @default.
• W2130897847 hasRelatedWork W2801544272 @default.
• W2130897847 hasRelatedWork W2913206873 @default.
• W2130897847 hasRelatedWork W3094923302 @default.
• W2130897847 hasRelatedWork W4386240674 @default.
• W2130897847 hasVolume "21" @default.
• W2130897847 isParatext "false" @default.
• W2130897847 isRetracted "false" @default.
• W2130897847 magId "2130897847" @default.
• W2130897847 workType "article" @default.